DE
Neuss
- GDP certification underlines UPS’s commitment to excellence and its ability to transport sensitive non-temperature controlled shipments throughout its German network.
- Patients and healthcare manufacturers and wholesalers benefit from endorsement of existing high standards throughout the supply chain.
UPS (NYSE:UPS) announced today that its services for pharmaceutical shipping in Germany are now Good Distribution Practice (GDP)-certified, meeting standards set by the European Union for the shipment of non-temperature controlled healthcare products for human use. With this certification granted by Deutsche Gesellschaft zur Zertifizierung von Managementsystemen (DQS), customers in the healthcare sector can be confident that their sensitive non-temperature controlled shipments are being handled with the highest level of care right up until the moment of final delivery.
“Healthcare packages containing pharmaceuticals or medical devices often require the highest standards for handling and transport—there is often so much more at stake than a typical package,” said Frank Sportolari, president, UPS Germany. “When it comes to healthcare, we at UPS understand it’s a patient, not a package. This certification will benefit all UPS customers and endorses what we and businesses have known for decades: UPS’s smart global logistics network is designed to meet the exacting requirements of our customers.”
The EU’s healthcare-product distribution standards are set by the European Medicines Agency, describing the conditions that a wholesale distributor must meet to ensure that the quality and integrity of medicines are maintained throughout the supply chain journey. Following an audit, UPS’s existing GDP-compliant procedures across its entire German network were certified to meet the specific requirements of the European Commission guideline 2013/C 343/01 for the non-temperature controlled transport of pharmaceutical products.
GDP certification is based on a range of assessment criteria, including quality control, employee training, safety, internal inspection procedures, and facility cleanliness. This certification means that the UPS network is suitable for shipping not only pharmaceuticals but also medical devices (implants, diagnostics and medical imaging), diagnostic products (including reagents), stable blood products, and cosmetics. Particularly for pharmaceutical and biopharmaceutical manufacturers, as well as for medical drug retailers, this certification is an endorsement of existing high standards throughout the supply chain that can reduce administration and simplify risk assessment processes when shipping with UPS.
This new certification demonstrates UPS’s commitment to deepening its global supply chain footprint in the top-tier healthcare and life sciences segments. As part of this, UPS aims to inspire trust and empower innovation across the healthcare and life sciences ecosystem. Four pillars will drive the company’s long-term logistics strategy for transportation, warehousing and distribution of critical healthcare and life science goods: quality assurance, visibility, control and customer experience.
UPS has a network of 14 dedicated healthcare logistics facilities across Europe with 600,000 square meters of warehouse space. The centerpiece of UPS’s healthcare network is its campus in Roermond/Venlo, the Netherlands, which is located in close proximity to the company’s European air hub in Cologne, from which UPS can connect Europe to the world and the world to Europe.
Acerca de UPS Healthcare
UPS provides global supply chain solutions and expertise to pharmaceutical, biopharma and medical device companies. UPS has approximately 8 million square feet of cGMP- or cGDP-compliant healthcare distribution space. UPS también mantiene una de las redes más extensas del mundo de ubicaciones de almacenamiento in situ con aproximadamente 900 centros. For parcels requiring strict temperature environments, from CRT to cryogenic, and those requiring around-the-clock monitoring, UPS has solutions such as UPS Temperature True™ and UPS Proactive Response™ services. UPS is committed to expanding its healthcare capabilities including recent acquisitions of Marken, CEMELOG and Poltraf, to meet the complex and evolving supply chain needs of the healthcare and life science sectors. Visite ups.com/healthcare.
Acerca de UPS
UPS (NYSE: UPS) es una de las compañías de transporte de paquetes más grandes del mundo, con unos ingresos en 2019 de 74 000 millones de USD, que proporciona una amplia gama de soluciones de logística integrada para clientes en más de 220 países y territorios. Más de 500 000 empleados de la empresa adoptan una estrategia que se ejecuta de manera simple y poderosa: El cliente es lo primero. Orientados a las personas. Nos motiva la innovación. UPS se compromete a proteger el medio ambiente y a contribuir positivamente a las comunidades a las que servimos en todo el mundo. UPS también mantiene una sólida e inquebrantable posición en apoyo de la diversidad, la igualdad y la inclusión. La empresa se encuentra en Internet en www.ups.com, con más información en www.pressroom.ups.com y www.investors.ups.com.